Mary C. Drummond

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Mary C.
Drummond is Senior Director-Oncology Commercial Development of Synta Pharmaceuticals Corp.
She joined Synta in April 2007.
Ms. Drummond held leadership positions in Millennium Pharmaceuticals oncology commercial organization, including key strategic and tactical roles for each of VELCADE's three indication launches.
Prior to Millennium, she was Senior Director of Sales and Marketing at Rosetta Inpharmatics and has held several marketing management roles in biotechnology and technology-focused companies.
Ms. Drummond received a BA from George Washington University and an Executive MBA from Pepperdine University.

Precedenti posizioni note di Mary C. Drummond

Società	Posizione	Fine
Rosetta Inpharmatics LLC Rosetta Inpharmatics LLC BiotechnologyHealth Technology Rosetta Inpharmatics LLC designed and implemented DNA microarray gene expression systems. The company provided software for use in informational genomics. The company was founded in may 29, 2009 and was headquartered in Seattle, WA.	Vendite & Marketing	-
Synta Pharmaceuticals Corp. Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Mary C. Drummond

Formazione di Mary C. Drummond

George Washington University	Undergraduate Degree
Pepperdine University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private